KDR and breast cancer: Interestingly, when these experiments were repeated using the immunocompetent 4T1 inflammatory breast cancer model, mcr84 and the VEGFR1 & VEGFR2 binding peptoid, GU81, were able to control tumor growth (Fig. 3A and B).